Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19 | NEJM
Original Article from The New England Journal of Medicine — Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
Original Article from The New England Journal of Medicine — Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
The U.S. Food and Drug Administration (FDA) has declined to approve Eli Lilly’s drug to treat a type of skin disease due to certain findings…
3 in 4 parents are concerned about the impact of air quality problems on their child’s health. 2 in 3 parents report poor or unhealthy…
But they acknowledge that taking the only shelf-accessible product off the market raises issues
Nestlé announced Monday the divestment of its peanut allergy treatment business Palforzia (peanut allergen powder-dnfp) to Stallergenes Greer for an undisclosed sum. Nestlé kicked off…
Illustrated Glossary from The New England Journal of Medicine
Illustrated Glossary from The New England Journal of Medicine
Illustrated Glossary from The New England Journal of Medicine
Illustrated Glossary from The New England Journal of Medicine
Pieris Pharmaceuticals announced partner AstraZeneca’s decision to discontinue clinical studies of elarekibep, an inhaled IL-4 receptor alpha inhibitor, based on a non-clinical toxicology study.
In an analysis of the primary outcome of this phase 3 trial, patients with early relapsed or refractory large B-cell lymphoma who received axicabtagene ciloleucel…